Rchr
J-GLOBAL ID：201801016576034921
Update date: Sep. 12, 2024
Junko Nagai
ナガイ ジュンコ | Junko Nagai
Affiliation and department：
Job title：
Senior Assistant Professor
Homepage URL (1)：
https://u-lab.my-pharm.ac.jp/~ir/index.html
Research field (1)：
Clinical pharmacy
Research theme for competitive and other funds (3)：
- 2019 - 2022 オピオイド使用高齢がん患者における抗コリン性副作用発現と医薬品との関連解析
- 2016 - 2019 Basic study of the possibility of newly synthesized 3-styrylchromone derivatives as therapeutic drugs for oral cancer
- 2015 - 2018 Adverse Reactions to Potent Opioids: An analysis using the largescale Japanese Adverse Drug Event Report database
Papers (20)：
-
Junko Nagai, Yoichi Ishikawa. Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database. PLOS ONE. 2021
-
Koichi Takao, Yuri Takemura, Junko Nagai, Hitoshi Kamauchi, Kaori Hoshi, Ryo Mabashi, Yoshihiro Uesawa, Yoshiaki Sugita. Synthesis and biological evaluation of 3-styrylchromone derivatives as selective monoamine oxidase B inhibitors. Bioorganic & medicinal chemistry. 2021. 42. 116255-116255
-
Yusuke Kan, Junko Nagai, Yoshihiro Uesawa. Evaluation of antibiotic-induced taste and smell disorders using the FDA adverse event reporting system database. Scientific reports. 2021. 11. 1. 9625-9625
-
Michito Teratani, Shouta Nakamura, Hiroshi Sakagami, Masakazu Fujise, Masashi Hashimoto, Noriyuki Okudaira, Kenjiro Bandow, Yosuke Iijima, Junko Nagai, Yoshihiro Uesawa, et al. Antitumor Effects and Tumor-specificity of Guaiazulene-3-Carboxylate Derivatives Against Oral Squamous Cell Carcinoma In Vitro. Anticancer research. 2020. 40. 9. 4885-4894
-
Yoshiaki Sugita, Koichi Takao, Yoshihiro Uesawa, Junko Nagai, Yosuke Iijima, Motohiko Sano, Hiroshi Sakagami. Development of Newly Synthesized Chromone Derivatives with High Tumor Specificity against Human Oral Squamous Cell Carcinoma. Medicines (Basel, Switzerland). 2020. 7. 9. 50-50
ｍore...
MISC (56)：
-
Junko Nagai. The relationship between demographic characteristics, GPA, and generic skills among the first-year students at Meiji Pharmaceutical University. 2024
-
永井純子, 東恭一郎, 越前宏俊. Institutional Research: A Fact-Finding Questionnaire Survey on the Faculty of Pharmacy at Private Universities in Japan. 日本薬学会年会要旨集(Web). 2024. 144th
-
熊谷美南, 永井純子, 植沢芳広. Classification evaluation of antineoplastic drugs that induce infectious disease using JADER. 日本薬学会年会要旨集(Web). 2021. 141st. 27P02-153S
-
薬丸実桜, 永井純子, 植沢芳広. Analysis of adverse effects of crude drugs included in Kampo preparations using JADER. 日本薬学会年会要旨集(Web). 2021. 141st. 27P02-158S
-
坂上 宏, 杉田 義昭, 高尾 浩一, 永井 純子, 植沢 芳広, 飯島 洋介, 佐野 元彦. 腫瘍選択性が高く,副作用が低い新規クロモン誘導体の開発-Development of newly synthesized chromone derivatives with high tumor specificity, but low adverse effects. New food industry = ニューフードインダストリー. 2020. 62. 12. 871-881
ｍore...
Lectures and oral presentations (5)：
-
2-Arylazoylchromonesと2-triazolylchromonesの定量的構造-細胞傷害性相関解析
(第141回日本薬理学会関東部会 2019)
-
シンポジウム18: 緩和医療薬学における副作用データベースの活用 副作用データベースを用いて鎮痛薬の副作用を科学する
(第13回日本緩和医療薬学会年会 2019)
-
ピラノ[4,3-b]クロモン誘導体の定量的構造-細胞傷害性相関解析
(第139回日本薬理学会関東部会 2018)
-
医薬品の副作用データに基づく定量的構造活性相関解析
(CBI学会2017年大会 2017)
-
医薬品副作用データベースに基づくがん患者における消化管障害を惹起する医薬品の評価
(第26回日本医療薬学会年会 2016)
Professional career (1)：
- Ph.D. (Meiji Pharmaceutical University)
Work history (5)：
- 2024/04 - 現在 Meiji Pharmaceutical University The Office of Institutional Research Senior Assistant Professor
- 2021/04 - 2024/03 Meiji Pharmaceutical University The Office of Institutional Research Assistant Professor
- 2022/08 - 2023/08 University of Florida, College of Pharmacy Department of Pharmaceutical Outcomes & Policy visiting scholar
- 2018/04 - 2021/03 Meiji Pharmaceutical University
- - 2018/03 Social Welfare Organization Saiseikai Imperial Gift Foundation inc. Saiseikai Kurihashi Hospital Department of pharmacy
Awards (1)：
- 2016/09 - 全国済生会病院薬剤師会 平成27年度全国済生会病院薬剤師会優秀論文賞 (2016)
Association Membership(s) (2)：
THE PHARMACEUTICAL SOCIETY OF JAPAN
, 日本緩和医療学会
